AstraZeneca plc vs TORM plc — how do they compare? AstraZeneca plc trades at $157.96 (market cap $248.14B), while TORM plc trades at $28.33 (market cap $2.93B). The key difference: AstraZeneca plc is far larger — about 84.7× TORM plc's market cap, and TORM plc pays the higher dividend (9.77%). Which is the better fit depends on your goals.
| AZN | TRMD | |
|---|---|---|
Market Cap | $248.14B | $2.93B |
Sector | Health | Technology |
52-Week High | $209.48 | $34.87 |
52-Week Low | $147.06 | $18.77 |
Enterprise Value | $275.41B | $3.82B |
Dividend Yield | 2.01% | 9.77% |
Trailing returns across standard periods
Latest headlines on both assets
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →TORM plc is one of the world's largest owners and operators of product tankers, specializing in the transportation of refined oil products like gasoline, jet fuel, and diesel. Operating under its integrated 'One TORM' model, the company maintains a modern, wholly-owned fleet of nearly 90 vessels. It is widely recognized by investors for its aggressive variable dividend policy, which returns a significant portion of its cash flow directly to shareholders during periods of high freight rates.
Read more on TRMD →